SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+9.24%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$387M
AUM Growth
+$387M
(-16%)
Cap. Flow
-$94.1M
Cap. Flow
% of AUM
-24.33%
Top 10 Holdings %
Top 10 Hldgs %
60.3%
Holding
49
New
8
Increased
8
Reduced
19
Closed
14
Top Buys
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$21M |
| 2 |
AGN
Allergan plc
AGN
|
$13.5M |
| 3 |
MiMedx Group
MDXG
|
$13.2M |
| 4 |
Sanofi
SNY
|
$12.7M |
| 5 |
Viatris
VTRS
|
$10.4M |
Top Sells
| 1 |
Abbott
ABT
|
$30.6M |
| 2 |
Biogen
BIIB
|
$24.6M |
| 3 |
Amgen
AMGN
|
$23.7M |
| 4 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$21.1M |
| 5 |
Universal Health Services
UHS
|
$15.4M |
Sector Composition
| 1 | Healthcare | 90.32% |
| 2 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $54.8M | 14.17% | 1,434,600 +331,300 | +30% | +$12.7M |
|
2
Eli Lilly
LLY
$657B
| $34.9M | 9.02% | 434,500 -167,300 | -28% | -$13.4M |
|
3
Elevance Health
ELV
$71.8B
| $27.5M | 7.1% | 219,200 +75,400 | +52% | +$9.45M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $26.7M | 6.91% | 137,900 -25,300 | -16% | -$4.9M |
|
|
ESRX
5
DELISTED
Express Scripts Holding Company
ESRX
| $21M | 5.43% | +297,700 | New | +$21M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $14.3M | 3.69% | 123,600 -39,100 | -24% | -$4.51M |
|
|
ELGX
7
DELISTED
Endologix Inc
ELGX
| $13.9M | 3.6% | 1,087,700 +277,900 | +34% | +$3.56M |
|
8
Enanta Pharmaceuticals
ENTA
$180M
| $13.5M | 3.49% | 506,900 +24,900 | +5% | +$663K |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $13.5M | 3.48% | +58,500 | New | +$13.5M |
|
|
10
MiMedx Group
MDXG
$1.05B
| $13.2M | 3.41% | +1,538,456 | New | +$13.2M |
|
11
Bausch Health
BHC
$2.74B
| $12M | 3.1% | 488,900 +323,500 | +196% | +$7.94M |
|
|
MNTA
12
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $11.2M | 2.91% | 962,098 +153,900 | +19% | +$1.8M |
|
13
Travere Therapeutics
TVTX
$1.56B
| $10.5M | 2.72% | 470,789 +141,300 | +43% | +$3.16M |
|
14
Molina Healthcare
MOH
$9.8B
| $10.5M | 2.71% | 179,700 +29,000 | +19% | +$1.69M |
|
|
15
Viatris
VTRS
$12.3B
| $10.4M | 2.7% | +273,500 | New | +$10.4M |
|
|
ALDR
16
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $9.72M | 2.51% | 296,670 -42,400 | -13% | -$1.39M |
|
|
CORI
17
DELISTED
Corium International, Inc.
CORI
| $9.03M | 2.33% | 1,603,066 -133,400 | -8% | -$751K |
|
18
Insmed
INSM
$28.8B
| $8.62M | 2.23% | 593,336 -195,600 | -25% | -$2.84M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $8.45M | 2.18% | 84,300 -10,000 | -11% | -$1M |
|
|
ADPT
20
DELISTED
Adeptus Health Inc.
ADPT
| $7.05M | 1.82% | +163,700 | New | +$7.05M |
|
21
Halozyme
HALO
$8.56B
| $6.65M | 1.72% | 550,544 -235,200 | -30% | -$2.84M |
|
|
CNCE
22
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $5.79M | 1.5% | 572,388 -228,400 | -29% | -$2.31M |
|
|
FOMX
23
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.85M | 1.25% | 523,397 -75,000 | -13% | -$695K |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $4.23M | 1.09% | +627,100 | New | +$4.23M |
|
|
ACOR
25
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $4M | 1.03% | 191,500 -166,691 | -47% | -$3.48M |
|